HS219

· KDL Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS219, covering 2012-06-01 to 2012-06-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia [Phase 2]